Dr Reddy’s Laboratories Ltd has announced its fourth quarterly results for the period till 31, March 2009.

The Pharmaceutical Company said that it has recorded a decline of 3.67% in net profit which stood at Rs 156 crore during the quarter under review, as compared to Rs 162 crore during the same quarter in fiscal 2008.

Company’s total income for the quarter has surged to Rs 1,166 crore from Rs 1038 crore in the year-ago period.

For the year ended March 31, 2009, the company has posted a net profit of Rs 560 crore against Rs 475 crore during fiscal 2008. Total revenue for the financial year 2009 went up to Rs 4,297 crore from Rs 3,584 crore last fiscal.

Further the company’s board has announced a final dividend of Rs 6 (125%) per equity share of Rs 5/- face value.

Stock price of Dr Reddys Laboratories settled in green at Rs 612, up 6.87% on National Stock Exchange (NSE). The total volume of shares traded on NSE was 707. Indian Stocks markets had limited trading on Monday as the stock indices were locked in upper circuit twice.